A. Relationship of Vaccines and Various Diseases |
| |
1. Allergy and Asthma |
| |
|
Abstract |
Intussusception among
infants given an oral rotavirus vaccine. Murphy TV, Gargiullo
PM, Massoudi MS, et al. N.Engl.J.Med. 2001; 344:
564-572. |
| |
|
Abstract |
Effects of
diphtheria-tetanus-pertussis or tetanus vaccination on allergies and
allergy-related respiratory symptoms among children and adolescents
in the United States. Hurwitz EL, Morgenstern H.
J.Manipulative Physiol Ther. 2000; 23: 81-90. |
| |
|
Abstract |
Does influenza
vaccination exacerbate asthma? Analysis of a large cohort of
children with asthma. Vaccine Safety Datalink Team. Kramarz P,
DeStefano F, Gargiullo PM, et al. Arch.Fam.Med. 2000; 9:
617-623. |
| |
|
Abstract |
Can immunization affect
the development of allergy? Pershagen G. Pediatr.Allergy
Immunol. 2000; 11 Suppl 13: 26-28. |
| |
|
Abstract |
Booster immunization of
children with an acellular pertussis vaccine enhances Th2 cytokine
production and serum IgE responses against pertussis toxin but not
against common allergens. Ryan EJ, Nilsson L, Kjellman N, et al.
Clin.Exp.Immunol. 2000; 121: 193-200. |
| |
|
Abstract |
[The effect of DPT and
BCG vaccinations on atopic disorders]. Yoneyama H, Suzuki M,
Fujii K, et al. Arerugi 2000; 49: 585-592. |
| |
|
Abstract |
Genetic and
environmental factors contributing to the onset of allergic
disorders. Parronchi P, Brugnolo F, Sampognaro S, et al.
Int.Arch.Allergy Immunol. 2000; 121: 2-9. |
| |
|
Abstract |
What is a safe vaccine?
Lonergan G, Rivest P. Vaccine 2000; 19: 1. |
| |
|
Abstract |
Postlicensure safety
surveillance for varicella vaccine. Wise RP, Salive ME, Braun
MM, et al. JAMA 2000; 284: 1271-1279. |
| |
|
Abstract |
Pertussis vaccination
and wheezing illnesses in young children: prospective cohort study.
The Longitudinal Study of Pregnancy and Childhood Team.
Henderson J, North K, Griffiths M, et al. BMJ 1999; 318:
1173-1176. |
| |
|
Abstract |
A clinical analysis of
gelatin allergy and determination of its causal relationship to the
previous administration of gelatin-containing acellular pertussis
vaccine combined with diphtheria and tetanus toxoids. Nakayama
T, Aizawa C, Kuno-Sakai H. J.Allergy Clin.Immunol. 1999; 103:
321-325. |
| |
|
Abstract |
Pertussis adjuvant
prolongs intestinal hypersensitivity. Kosecka U, Berin MC,
Perdue MH. Int.Arch.Allergy Immunol. 1999; 119:
205-211. |
| |
|
Abstract |
A randomized controlled
trial of the effect of pertussis vaccines on atopic disease.
Nilsson L, Kjellman NI, Bjorksten B. Arch.Pediatr.Adolesc.Med.
1998; 152: 734-738. |
| |
|
Abstract |
Early childhood
infection and atopic disorder. Farooqi IS, Hopkin JM. Thorax
1998; 53: 927-932. |
| |
|
Abstract |
Give us this day our
daily germs. Rook GA, Stanford JL. Immunol.Today 1998; 19:
113-116. |
| |
|
Abstract |
Is infant immunization a
risk factor for childhood asthma or allergy? Kemp T, Pearce N,
Fitzharris P, et al. Epidemiology 1997; 8: 678-680. |
| |
|
Abstract |
Lack of association
between pertussis vaccination and symptoms of asthma and allergy.
Nilsson L, Kjellman NI, Storsaeter J, et al. JAMA 1996;
275: 760. |
| |
|
Abstract |
Pertussis vaccination
and asthma: is there a link? Odent MR, Culpin EE, Kimmel T.
JAMA 1994; 272: 592-593. |
| |
|
Abstract |
Adverse Events
Associated with Childhood Vaccines: Evidence Bearing on Causality.
Vaccine Safety Committee IOM. Washington, D.C.: National Academy
Press, 1994. |
| |
|
Abstract |
Adverse events following
pertussis and rubella vaccines. Summary of a report of the Institute
of Medicine. Howson CP, Fineberg HV. JAMA 1992; 267:
392-396. |
| |
|
Abstract |
Adverse Effects of
Pertussis and Rubella Vaccines: A Report of the Committee to review
the Adverse Consequences of Pertussis and Rubella Vaccines.
Committee to Review the Adverse Consequences of Pertussis and
Rubella Vaccines IOM. National Academy Press, Washington D.C., 1991. |
| |
|
Abstract |
Pertussis booster
vaccination and immediate hypersensitivity. Gifford CG, Gonsior
EC, Villacorte GV, et al. Ann.Allergy 1985; 54:
483-485. |
| |
2. Autism |
| |
|
Abstract |
Measles-Mumps-Rubella
Vaccine and Autism. Immunization Safety Review Committee IOM.
Kathleen Stratton, Alicia Gable Padma Shetty and Marie McCormick
Editors. 2001. Washington, D.C., National Academy Press. |
| |
|
Abstract |
Endangering Public
Health. The Washington Post, A20. 2001. Washington D.C. |
| |
|
Abstract |
Thimerosal-containing
Vaccines and Neurodevelopmental Disorders. Immunization Safety
Review Committee IOM. Kathleen Stratton, Alicia Gable and Marie
McCormick Editors. 2001. Washington, D.C., National Academy Press. |
| |
|
Abstract |
Time trends in autism
and in MMR immunization coverage in California. Dales L, Hammer
SJ, Smith NJ. JAMA 2001; 285: 1183-1185. |
| |
|
Abstract |
Mumps, measles, and
rubella vaccine and the incidence of autism recorded by general
practitioners: a time trend analysis. Kaye JA, Mar Melero-Montes
M, Jick H. BMJ 2001; 322: 460-463. |
| |
|
Abstract |
Measles-mumps-rubella
vaccine and autistic spectrum disorder: report from the New
Challenges in Childhood Immunizations Conference convened in Oak
Brook, Illinois, June 12-13, 2000. Halsey NA, Hyman SL.
Pediatrics 2001; 107: E84. |
| |
|
Abstract |
On autism: Its
prevalence, diagnosis, causes and treatment. Gleberzon B,
Rosenberg-Gleberzon A. Topics in Clinical Chiropractic 2001;
8: 42-57. |
| |
|
Abstract |
Autism: Present
Challenges, Future Needs--Why The Increased Rates? 106-180.
2000. Washington D.C., U.S. Government Printing Office. |
| |
|
Abstract |
Measles-mumps-rubella
immunisation, autism and inflammatory bowel disease: update.
Amin J, Wong M. Commun.Dis.Intell. 1999; 23: 222. |
| |
3. Central Nervous
System Sequelae and Sudden Infant Death Syndrome |
| |
|
Abstract |
The risk of seizures
after receipt of whole-cell pertussis or measles, mumps, and rubella
vaccine. Barlow WE, Davis RL, Glasser JW, et al. N.Engl.J.Med.
2001; 345: 656-661. |
| |
|
Abstract |
Hepatitis B vaccine and
central nervous system demyelinating diseases. Viral Hepatitis
Prevention Board. Halsey NA, Duclos P, Van Damme P, et al.
Pediatr.Infect.Dis.J. 1999; 18: 23-24. |
| |
|
Abstract |
The protective effect of
immunisation against diphtheria, pertussis and tetanus (DPT) in
relation to sudden infant death syndrome. Essery SD, Raza MW,
Zorgani A, et al. FEMS Immunol.Med.Microbiol. 1999; 25:
183-192. |
| |
|
Abstract |
Pertussis immunization:
An update. Morgan LG. J Can Chiropr Assoc 1997; 41:
86-90. |
| |
|
Abstract |
Risk of serious acute
neurological illness after immunization with
diphtheria-tetanus-pertussis vaccine. A population-based
case-control study. Gale JL, Thapa PB, Wassilak SG, et al.
JAMA 1994; 271: 37-41. |
| |
|
Abstract |
Risk of sudden infant
death syndrome after immunization with the
diphtheria-tetanus-pertussis vaccine. Griffin MR, Ray WA,
Livengood JR, et al. N.Engl.J.Med. 1988; 319: 618-623. |
| |
4. Diabetes |
| |
|
Abstract |
Childhood immunizations
and type 1 diabetes: summary of an Institute for Vaccine Safety
Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel.
Pediatr.Infect.Dis.J. 1999; 18: 217-222. |
| |
|
Abstract |
No evidence that
vaccines cause insulin dependent diabetes mellitus. Jefferson T,
Demicheli V. J.Epidemiol.Community Health 1998; 52:
674-675. |
| |
|
|
The timing of pediatric
immunization and the risk of insulin-dependant diabetes mellitus.
Classen JB, Classen DC. Infectious Diseases in Clinical
Practice 1997; 6: 449-454. |
| |
|
Abstract |
The timing of
immunization affects the development of diabetes in rodents.
Classen JB. Autoimmunity 1996; 24: 137-145. |
| |
5. Multiple Sclerosis |
| |
|
Abstract |
Vaccinations and the
risk of relapse in multiple sclerosis. Vaccines in Multiple
Sclerosis Study Group. Confavreux C, Suissa S, Saddier P, et al.
N.Engl.J.Med. 2001; 344: 319-326. |
| |
|
Abstract |
Hepatitis B vaccination
and the risk of multiple sclerosis. Ascherio A, Zhang SM, Hernan
MA, et al. N.Engl.J.Med. 2001; 344: 327-332. |
| |
6. Other/General |
| |
|
Abstract |
Commentary on Potential
Risk From Thimerosal for Infants . Halsey N. Institute for
Vaccine Safety, Johns Hopkins University. 2001. |
| |
|
Abstract |
Update: vaccine side
effects, adverse reactions, contraindications, and precautions.
Recommendations of the Advisory Committee on Immunization Practices
(ACIP). CDC. MMWR Recomm.Rep. 1996; 45: 1-35. |
| |
|
Abstract |
Adverse events
associated with childhood vaccines other than pertussis and rubella.
Summary of a report from the Institute of Medicine. Stratton KR,
Howe CJ, Johnston RB, Jr. JAMA 1994; 271: 1602-1605. |
B. Vaccine Adverse Event Reporting System (VAERS), and
reviews/commentary/discussions of vaccine safety and risk. |
| |
|
Abstract |
Safety considerations
for new vaccine development. Ellenberg SS.
Pharmacoepidemiol.Drug Saf 2001; 10: 411-415. |
| |
|
Abstract |
Vaccine safety: risk
communication--a global perspective. Dittmann S. Vaccine
2001; 19: 2446-2456. |
| |
|
Abstract |
Conflict of interest
taints vaccine approval process, charges US report. McCarthy M.
Lancet 2000; 356: 838. |
| |
|
Abstract |
Withdrawal of rotavirus
vaccine recommendation. CDC. MMWR Morb.Mortal.Wkly.Rep.
1999; 48: 1007. |
| |
|
Abstract |
An overview of the
vaccine adverse event reporting system (VAERS) as a surveillance
system. VAERS Working Group. Singleton JA, Lloyd JC, Mootrey GT,
et al. Vaccine 1999; 17: 2908-2917. |
| |
|
Abstract |
Vaccination and its
adverse effects: real or perceived. Society should think about means
of linking exposure to potential long term effect. Jefferson T.
BMJ 1998; 317: 159-160. |
